Based in an old Bermondsey biscuit factory, this London cancer drug firm just raised millions May 21, 2024 Founded in 2012 by a PhD student, Labgenius uses technology to create more effective and safer antibodies for cancer treatment.
‘New era of growth’: FTSE 100 giant Astrazeneca aims to double revenue May 21, 2024 London-listed Astrazeneca reported revenue of $45.8bn in 2023 and growth of 19 per cent to $12.7bn in the first quarter of 2024.
‘Day of shame’: Rishi Sunak apologises for infected blood scandal May 20, 2024 Rishi Sunak has made a “wholehearted and unequivocal apology” for the infected blood scandal in what he said was a “day of shame” for the British state.
Astrazeneca to build huge new cancer drug plant in Singapore May 20, 2024 Astrazeneca has said it will invest $1.5bn (£1.2bn) to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment.
How business leaders can embrace shift to healthier office dining May 20, 2024 The healthier office landscape is in a constant state of evolution, and the recent embrace of hybrid work models has only accelerated these changes.
Ozempic and Wegovy: What happens when a drug goes viral? May 18, 2024 Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?
Let’s be honest: ‘miracle drug’ Ozempic will be a game-changer on obesity May 16, 2024 What if there was already a proven way to reduce obesity and improve health without government intervention? There is and it’s called Ozempic, says Matt Lesh A new study out this week claims that rising work absenteeism is being driven by obesity. There are reasons to doubt these findings. Official data from the Office for [...]
Polar Capital Healthcare trust rockets to success thanks to strong stock selection May 16, 2024 The trust performed much better than the previous year, where it grew only 4.2 per cent, thanks to strong stock selection and managing to outperform an already booming healthcare market.
When the drugs don’t work: How the UK became addicted to antidepressants May 14, 2024 Almost one in four adults are being prescribed antidepressants, but they are not as effective as was once believed, writes Lucy Kenningham
Long-term sickness now top reason for women being out of work May 13, 2024 Long-term sickness has become the main reason for women being out of work, according to research by one trade union.